Rare diseases
Investigational molecules
Locations
Back to Germany1 118 clinical trials in Sankt Augustin, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
GermanyStudy of Sotatercept for People with Pulmonary Arterial Hypertension
GermanyStudy on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
GermanyStudy on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
GermanyStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
GermanyStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
GermanyStudy on the Safety and Effectiveness of Motixafortide and G-CSF for Stem Cell Collection in Patients with Multiple Myeloma
GermanyLong-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria
GermanyStudy on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors
GermanyStudy on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for juvenile arthritis conditions, including studies of medications like baricitinib, ustekinumab, and bimekizumab for various forms of JIA.
Research aims to evaluate drug efficacy and safety in pediatric populations with autoimmune conditions.
Comprehensive studies on childhood cancers, with particular focus on leukemia and lymphoma treatments, including novel therapeutic approaches and combination therapies.
Investigations include targeted therapies and personalized treatment protocols for various cancer stages.
Specialized research into brain and nervous system tumors, focusing on ependymoma and medulloblastoma treatment strategies.
Studies evaluate surgical outcomes, radiation therapy approaches, and chemotherapy effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
